Imatinib drugs market was valued at $1.80 billion in 2025 and is projected to reach $2.52 billion by 2035, growing at a CAGR of 4.3% during the forecast period (2026–2035). The market growth is primarily driven by the rising global burden of cancer, particularly hematological malignancies. According to the World Health Organization, cancer accounted for nearly 10 million deaths worldwide in 2022, with leukemia representing a significant share of cases. Imatinib remains a first-line targeted therapy for Chronic Myeloid Leukemia (CML) and other rare cancers, supporting sustained demand. Increasing access to generic imatinib formulations, especially in emerging economies, is further expanding patient reach and improving affordability, thereby strengthening market growth.

Hydraulic pump market was valued at $11.3 billion in 2025 and is projected to reach $16.63 billion by 2035, growing at a CAGR of 3.33% during the forecast period (2026-2035). The rising global infrastructure development is strengthening demand for hydraulic systems across construction, mining, and industrial applications. According to the International Energy Agency, global infrastructure investment requirements are expected to exceed $3 trillion annually through 2030, driven by urbanization and energy transition projects. Hydraulic pumps play a critical role in ensuring efficient fluid power transmission, enabling precision control, high load handling, and operational efficiency in heavy machinery. The market is witnessing steady adoption of advanced electro-hydraulic technologies as manufacturers upgrade equipment platforms.

Hunter syndrome treatment market was valued at $1.07 billion in 2025 and is projected to reach $2.15 billion by 2035, growing at a CAGR of 7.23% during the forecast period (2026–2035). The increasing prevalence of rare genetic disorders and rising focus on orphan drug development are key macro drivers supporting market growth. According to the World Health Organization, rare diseases affect approximately 400 million people globally, highlighting the significant unmet need for specialized treatments. Hunter syndrome (MPS II), a rare lysosomal storage disorder, requires long-term therapeutic intervention such as enzyme replacement therapy and gene therapy. Increasing regulatory support for orphan drugs and advancements in biotechnology are accelerating the development and commercialization of innovative treatment options.

Esomeprazole market was valued at $2.01 billion in 2025 and is projected to reach $3.62 billion by 2035, growing at a CAGR of 6.05% during the forecast period (2026–2035). The increasing global burden of gastrointestinal disorders is significantly driving demand for proton pump inhibitors, particularly esomeprazole. Rising prevalence of gastroesophageal reflux disease (GERD), peptic ulcer disease, and acid-related disorders is strengthening the need for effective acid suppression therapies across both developed and emerging markets. Additionally, increasing consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) is contributing to higher incidence of gastric complications, further supporting sustained demand for esomeprazole-based treatments. 

Corticosteroids market was valued at $6.20 billion in 2025 and is projected to reach $10.29 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The rising prevalence of chronic inflammatory and respiratory diseases is significantly strengthening demand for corticosteroid-based therapies across global healthcare systems. According to the World Health Organisation, chronic respiratory diseases such as asthma and COPD affect over 550 million people worldwide, driving sustained demand for anti-inflammatory medications, including corticosteroids. These drugs play a critical role in reducing inflammation, suppressing immune responses, and managing disease progression across multiple therapeutic areas. The increasing burden of allergic and autoimmune disorders is further accelerating market expansion.

Cider market was valued at $5.48 billion in 2025 and is projected to reach $8.61 billion by 2035, growing at a CAGR of 4.6% during the forecast period (2026–2035). The increasing global demand for low-alcohol and fruit-based beverages across social and lifestyle consumption is a key macro driver supporting market growth. According to the World Health Organization (WHO), global per capita alcohol consumption stood at approximately 5.5 litres in 2019, reflecting consistent demand across developed and emerging economies. Cider plays an important role in this landscape as a naturally fermented beverage made from apples and other fruits, offering a gluten-free and flavoured alternative to traditional beer. Rising consumer inclination toward premium, craft, and flavoured alcoholic beverages is strengthening cider demand across retail and hospitality sectors globally.

CBRNE defense market was valued at $16.55 billion in 2025 and is projected to reach $25.70 billion by 2035, growing at a CAGR of 4.5% during the forecast period (2026–2035). The rising global focus on chemical, biological, radiological, nuclear, and explosive threat preparedness is significantly strengthening demand for advanced detection, protection, and response systems. Increasing geopolitical tensions, asymmetric warfare risks, and terrorist threats are compelling governments to enhance national security frameworks and invest in CBRNE defense capabilities. According to the Stockholm International Peace Research Institute (SIPRI), global military expenditure reached $2.44 trillion in 2023, reflecting continued investment in defense modernization and security infrastructure. 

Bionics market was valued at $26.5 billion in 2025 and is projected to reach $64.0 billion by 2035, growing at a CAGR of 9.2% during the forecast period (2026-2035). The rising prevalence of disabilities, neurological disorders, and mobility impairments is significantly driving demand for advanced bionic devices across healthcare systems. Bionic technologies, including prosthetic limbs, neural implants, cochlear devices, and exoskeleton systems, play a critical role in restoring physical functions, improving patient mobility, and enhancing quality of life. The increasing integration of artificial intelligence and microprocessor-controlled systems is further strengthening product efficiency, precision, and adaptability in real-time clinical applications. Hospitals and rehabilitation centres remain the primary demand contributors, supported by increasing surgical procedures and post-operative rehabilitation requirements.

Automated poultry market was valued at $5.49 billion in 2025 and is projected to reach $10.27 billion by 2035, growing at a CAGR of 6.46% during the forecast period (2026–2035). The increasing global demand for poultry products, coupled with the need for operational efficiency and biosecurity, is significantly driving the adoption of automated systems across poultry farms. According to the Food and Agriculture Organization, global poultry meat production exceeded 138 million tonnes in 2023 and continues to grow steadily due to rising protein consumption, particularly in emerging economies. This surge in demand is compelling producers to adopt automation technologies such as feeding, 

Artillery systems market was valued at $11.88 billion in 2025 and is projected to reach $19.01 billion by 2035, growing at a CAGR of 4.8% during the forecast period (2026–2035). The increasing global defense expenditure and modernization of armed forces are acting as key macro drivers supporting market growth. According to data from the Stockholm International Peace Research Institute (SIPRI), global military expenditure reached over $2.4 trillion in 2024, reflecting continued geopolitical tensions and national security priorities. Artillery systems remain critical for long-range firepower, battlefield dominance, and precision strike capabilities, leading to sustained procurement and upgrade programs across both developed and emerging economies. The integration of advanced targeting, mobility, and automated fire control systems is further enhancing operational efficiency and driving demand across modern defense infrastructures.